Syuzanna Harutyunyan, professor of Synthetic Organic Chemistry, is the Royal Society of Chemistry Homogeneous Catalysis Award winner for 2017. Her work focuses on developing new methods to synthesise molecules that are useful in the pharmaceutical, fine-chemical or agrochemical industries. Professor Harutyunyan receives £2000, a medal and a certificate.
“Many commonly used methods are very inefficient and produce much more waste than the desired product,” Syuzanna explains. “Our new strategies are not only aimed at making compounds that were not available before, but also at providing better and more sustainable alternatives to existing methodologies. In this way my research contributes to a future with better drugs and a cleaner environment.”
On receiving the award, she said: “I am delighted to receive this award. It is an honour to have been selected out of so many excellent scientists that work in this field, and a great recognition of the work my group and I have done. I’m looking forward to sharing and discussing the latest results of our research during the lecture tour.”
The Royal Society of Chemistry (RSC) is a leading chemistry community, advancing excellence in the chemical sciences. With over 50,000 members and 175 years of history, it is the UK’s professional non-profit body for chemical scientists over the world. RSC Award winners are evaluated for the originality and impact of their research, as well as the quality of the results, which can be shown in publications, patents, or even software.
Prof. Syuzanna Harutyunyan
Royal Society of Chemistry
The University of Groningen (UG) will soon have a new Bachelor’s degree programme on offer: Biomedical Engineering.
If you are a black-tailed godwit (Limosa limosa limosa), your biannual migrations over the Sahara desert may prove fatal. Black-tailed godwits that breed in the Netherlands mostly spend their winters in West Africa, and so they fly over the Sahara twice...
Parkinson’s disease causes brain cells that produce the neurotransmitter dopamine to die. But where does the disease start? Evidence suggests that a failure of the brain’s immune system may be the root cause of the disease.